First subject enrolled in phase III study of TRC-101 in chronic kidney disease Sep. 29, 2017 No Comments
FDA accepts for review sNDA for mirabegron in combination with solifenacin for overactive bladder Sep. 14, 2017 No Comments
Bayer enters kidney disease collaboration with Vanderbilt University Medical Center Sep. 12, 2017 No Comments
Enrollment completed in phase IIb study of BGS-649 for hypogonadotropic hypogonadism Sep. 5, 2017 No Comments
Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy Aug. 30, 2017 No Comments
RSS